• Premature birth (Clinical lecture)

Premature birth (Clinical lecture)

HEALTH OF WOMAN. 2018.4(130):9–13; doi 10.15574/HW.2018.130.9

Ventskovskaya I. B., Bila V. V., Zagorodnya O.S.
Bogomolets National Medical University, Kiev
Perinatal center, Kiev

The article presents modern views on the pathogenesis of preterm labor, their relevance and classification. From the perspective of evidence-based medicine methods of prevention are considered. A comparison of the main tocolytic agents, their advantages and disadvantages is presented.
Key words: premature birth, perinatal and infantile mortality, tocolysis, magnesium sulfate, gestational age.

REFERENCES

1. Ventskovskiy BM, Leush SSt, Zagorodnyaya AS. 2015. Polimorfizm genov folatnogo obmena kak prichina prezhdevremennyih rodov. Reproduktivnoe zdorove. Vostochnaya Evropa. 4(40):8–15.

2. Zahorodnia OS. 2018. Tokolityky dlia poperedzhennia peredchasnykh polohiv. Z turbotoiu pro zhinku 1(85):48–49.

3. Ventskivska IB, Bila VV, Podolskyi VV, Zahorodnia OS. 2016. Peredchasni polohy – patohenez, prohnozuvannia ta profilaktyka. Metodychni rekomendatsii. Kyiv:30.

4. ACOG practice bulletin. Management of preterm labor 43. 2003, May. Obstet Gynecol  101:1039-47.

5. Alfirevic Z, Stampalija T, Medley N. 2017, June 6. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Editorial Group: Cochrane Pregnancy and Childbirth Group. https://doi.org/10.1002/14651858.CD008991.pub3

6. Crowther C, Hiller J, Doyle L. 2002. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews 4. Art. No.: CD001060. https://doi.org/10.1002/14651858.CD001060; PMid:12519550

7. Goldenberg R, Culhane JF, Iams JD, Romero R. 2008. Epidemiology and causes of preterm birth. The Lancet. 371;9606:75–84. https://doi.org/10.1016/S0140-6736(08)60074-4

8. Haas D, Caldwell D, Kirkpatrick J, Welton N. 2012. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 345:e6226, https://doi.org/10.1136/bmj.e6226

9. Hamilton B, Martin J, Ventura S. 2010. Births: preliminary data for 2009. Natl Vital Stat Rep. 59(3):1–19. http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_03.pdf

10. Institute of Medicine. Preterm birth: causes, consequences, and prevention. Washington, DC: National Academies Press. 2007.

11. King F, Flenady V. 2002. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database of Systematic Reviews 4. Article ID CD000246. https://doi.org/10.1002/14651858.CD000246

12. Kumar D, Springel E, Moore A. 2015. Progesterone inhibits in vitro fetal membrane weakening. Am J Obstet Gynecol. 213:520.e1. https://doi.org/10.1016/j.ajog.2015.06.014; PMid:26070709

13. Magnesium sulfate before anticipated preterm birth for neuroprotection. Committee Opinion No. 455. American College of Obstetricians and Gynecologists. Obstet Gynecol 115:669–71. 2010. https://doi.org/10.1097/AOG.0b013e3181d4ffa5; PMid:20177305

14. Martin J, Hamilton BE, Sutton PD et al. 2010. Births: final data for 2007. National Vital Statistics Reports. 58;24:1–88. PMid:21254725

15. Nygren P, Fu R, Freeman M, Bougatsos C, Klebanoff M, Guise J. 2008. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med. 148(3):220–33. https://doi.org/10.7326/0003-4819-148-3-200802050-00008

16. O’Brien J, Lewis D. 2016. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. Am J Obstet Gynecol. 214:45. https://doi.org/10.1016/j.ajog.2015.10.934; PMid:26558340

17. Practice Bulletin 171. Management of Preterm Labor. Obstetrics & Gynecology:  2016, October. 128; 4: e155–e164. https://doi.org/10.1097/AOG.0000000000001711

18. Romero R, Nicolaides K, Conde-Agudelo A et al. 2012. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am.J.Obstet Gynecol. 206(2):e.1-9.

19. Rouse D, Hirtz D, Thom E. 2008. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 28;359(9):895–905.

20. Savitz D, Terry J, Dole N, Thorp J, Siega-Riz A, Herring A. 2002. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol. 187;6:1660–6. https://doi.org/10.1067/mob.2002.127601

21. Subramaniam A, Abramovici A, Andrews W, Tita A. 2012. Antimicrobials for Preterm Birth Prevention: An Overview. Infectious Diseases in Obstetrics and Gynecology 45:78–90. https://doi.org/10.1155/2012/157159